India Plasma Fractionation Market Size, Share & COVID-19 Impact Analysis, By Product (Albumin, Immunoglobulin, Coagulation Factors (Factor VIII, Factor IX, and Others), and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology, and Others), By End-user (Hospitals & Clinics, Research Organizations, and Others), and Forecast, 2021-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI106442

THANK YOU

FOR YOUR INTEREST IN OUR REPORT

Are you interested in exploring our consulting services?

I want to learn more about:

Competitive Intelligence Opportunity Assessment Distribution & Supply Chain Analysis Book a consultation to discuss your needs

Market Entry Strategy Go-to-market Strategy Others (Please specify)

Table of Content

Introduction
1. Market Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
Key Insights
1. Key Industry Developments
2. Impact of COVID-19 on India Plasma Fractionation Market
3. Overview: Plasma Fractionation Regulations in India
4. Insights: Plasma Fractionation Production Capacity in India
5. Future Strategies of India Plasma Fractionation Companies
6. Overview: Investment Initiatives in India Plasma Fractionation Market
7. Government of India's View on Self-Sufficiency on Plasma-derived medicinal products (PDMPs)
8. Supply Chain Analysis
India Plasma Fractionation Market Analysis, Insights and Forecast, 2017-2030
1. Key Findings / Summary
2. Market Analysis, Insights and Forecast – By Product
  1. Albumin
  2. Immunoglobulin
  3. Coagulation Factors
    1. Factor VIII
    2. Factor IX
    3. Others
  4. Others
3. Market Analysis, Insights and Forecast – By Application
  1. Immunology & Neurology
  2. Hematology
  3. Critical Care
  4. Pulmonology
  5. Others
4. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Research Organizations
  3. Others
Competitive Analysis
1. India Market Share Analysis (2020)
2. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. PlasmaGen
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  2. Reliance Life Sciences
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  3. Biocon Limited
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  4. Intas Pharmaceuticals Ltd.
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  5. Bharat Serums and Vaccines Limited (BSV)
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  6. Hemarus
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  7. Kedrion S.p.A
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  8. Fusion Healthcare
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)
  9. VIRCHOW BIOTECH
    1. Overview,
    2. Products & Services,
    3. SWOT Analysis,
    4. Recent Developments,
    5. Strategies,
    6. Financials (Based on Availability)